首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Herzschrittmachertherapie und elektrophysiologie

缩写:

ISSN:0938-7412

e-ISSN:1435-1544

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引1092
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
C Meyer,M Martinek,S Winter et al. C Meyer et al.
The population of adults with surgically corrected tetralogy of Fallot (TOF) is increasing. Atrial and ventricular arrhythmias are prevalent, and therapeutical approaches including implantable cardioverter-defibrillators and radiofrequency ...
E Wunderlich,H Schindler,A Hetze et al. E Wunderlich et al.
Background: In isolated sinus node disease single lead atrial stimulation is recommended. However, an inherent risk includes emerging AV node disturbances with serious bradycardia in the follow-up. This possible scenario ...
K Rybak K Rybak
Implantable devices in cardiac electrophysiology have developed from simple machines that prevent bradycardia to complex systems that treat malignant tachyarrhythmias and severe heart failure. Optimal therapeutic utilization of these system...
M Nabauer,A Gerth,P Kirchhof et al. M Nabauer et al.
The German Competence Network on Atrial Fibrillation (AFNET) is a national interdisciplinary research network funded by the Federal Ministry of Education and Research (BMBF). AFNET was initiated in 2003 and aims at improving treatment of at...
U K H Wiegand,B Lemke,B Nowak U K H Wiegand
The German obligatory external quality assurance for pacemaker implantation generates a large database giving an almost complete review of in-patient pacemaker interventions since 2001. Publications on lead fixation, age and gender dependen...
K-H Ladwig,J Ronel,J Baumert et al. K-H Ladwig et al.
Currently, the method of choice for protection against sudden cardiac death for high-risk patients is ICD treatment. The CIDS study could prove a significant advantage of ICD treatment compared to amiodarone therapy. However, the survival a...
D Bänsch,G Grönefeld D Bänsch
An expansion of the indications for the implantation of defibrillators (ICD) has not occurred as such in recent years. Nevertheless, an increase in the number of implantation figures can be expected due to the aging population and an increa...
N C Ewertsen,G Steinbeck,J Senges et al. N C Ewertsen et al.
There is high mortality during the first few weeks after an acute myocardial infarction. However, according to the guidelines, the prophylactic implantation of an ICD, given the corresponding risk constellation, is recommended not earlier t...
C W Israel C W Israel
ICD therapy represents a major advance in the treatment of patients with severely impaired left ventricular function after myocardial infarction. While an ICD implantation also remains a valuable option late (>5 years) after myocardial infa...
C W Israel C W Israel
A patient with heart failure functional class NYHA III and permanent atrial fibrillation received a system for cardiac resynchronization therapy. Unfortunately, he reports at a follow-up visit about a completely unchanged poor exercise capa...